Ụlọ ọrụ mmepụta ihe China 99% Ọcha Tofacitinib Citrate/Xeljanz Raw Powder 540737-29-9
N'ime afọ ole na ole gara aga, ụlọ ọrụ anyị na-etinye uche ma gbarie teknụzụ mepere emepe nke ọma n'ụlọ na ná mba ọzọ.Ka ọ dị ugbu a, anyị azụmahịa mkpara otu ndị ọkachamara raara onwe ha na uto nke Factory N'ogbe China 99% Ọcha Tofacitinib Citrate / Xeljanz Raw ntụ ntụ 540737-29-9, Ka ọ dị ugbu a, aha ụlọ ọrụ nwere ọtụtụ ihe karịrị 4000 ụdị ngwaahịa ma nweta ezigbo ọnọdụ. na nnukwu òkè na ahịa ugbu a n'ime ụlọ na mba ọzọ.
N'ime afọ ole na ole gara aga, ụlọ ọrụ anyị na-etinye uche ma gbarie teknụzụ mepere emepe nke ọma n'ụlọ na ná mba ọzọ.Ka ọ dịgodị, anyị azụmahịa mkpara otu ndị ọkachamara raara onwe ya nye na uto nkeChina 540737-29-9, Ọnụ ego Tofacitinib Citrate, N'ihi ezigbo mma na ọnụ ahịa ezi uche dị na ya, a na-ebupụ ngwaahịa anyị na mba na mpaghara 10 karịa.Anyị na-atụ anya ịkwado ndị ahịa niile si n'ụlọ na mba ọzọ.Ọzọkwa, afọ ojuju ndị ahịa bụ nchụso ebighi ebi anyị.
Ngwaahịaaha | Yohimbine hydrochloride |
Ụdị okwu | 17-Hydroxy-yohimban-16-carboxylic acid methyl ester hydrochloride. |
Nhazi | |
CAS Mba. | 65-19-0 |
Ọdịdị | White ma ọ bụ gbanyụọ ọcha ntụ ntụ |
Usoro ihe omimi | C21H26N2O3.HCl |
Ibu molekụla | 390.91 |
Ngwa | Ọkwa ọgwụ ma ọ bụ ebumnuche nyocha |
Nkwakọ ngwaahịa | Dị ka arịrịọ gị si dị |
Nchekwa | Chekwaa n'ime akpa siri ike, nke na-enweghị ọkụ n'ebe dị mma |
Yohimbine hydrochloride Ọnọdụ: 65-19-0 | ||
NGWA | Ọkọlọtọ | Nsonaazụ |
Ọdịdị | Gbanyụọ ntụ ntụ ọcha | Gbanyụọ ntụ ntụ ọcha |
Isi & uto | Njirimara | Njirimara |
Identification | HPLC, dị mma maka Yohimbe alkaloids | Na-akwado |
Loss na ihicha | 2% | 0.82% |
Ihe fọdụrụ na mgbanye | 3% | 1.88% |
Nnukwu njupụta | 0.40-0.60g / ml | 0.44g / ml |
Yohimbine (HPLC) | ≥98% | 98.2% |
Ọla dị arọ (dị ka Pb) | ≤10ppm | ≤10ppm |
Mkpokọta arsenic (dị ka As) | ≤1.0pm | ≤1.0pm |
Ndu (Pb) | ≤1.0pm | ≤1.0pm |
Cadmium (Cd) | ≤1.0pm | ≤1.0pm |
Mercury (Hg) | ≤1.0pm | ≤1.0pm |
Aflatoxins (HPLC) | Ihe ọjọọ | Ihe ọjọọ |
Mmechi: Ọ na-akwado ụkpụrụ ụlọ ọrụ edepụtara. |